Last reviewed · How we verify
Identification of biological markers — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Identification of biological markers (Identification of biological markers) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Identification of biological markers TARGET | Identification of biological markers | Assistance Publique - Hôpitaux de Paris | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Identification of biological markers CI watch — RSS
- Identification of biological markers CI watch — Atom
- Identification of biological markers CI watch — JSON
- Identification of biological markers alone — RSS
Cite this brief
Drug Landscape (2026). Identification of biological markers — Competitive Intelligence Brief. https://druglandscape.com/ci/identification-of-biological-markers. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab